Imaging studies of kidney cancer
DOI:
https://doi.org/10.15584/ejcem.2019.4.8Keywords:
Kidney cancer, MRI, PEAbstract
Introduction. In 2017 in the USA about 5% in men and 3% in women newly diagnosed cases of malignant tumors were kidney and renal pelvis cancer.
Aim. Kidney cancer in adults includes malignant tumors derived from kidney parenchyma and renal pelvis. The dominating types are kidney parenchyma, and mainly renal cell carcinomas.
Material and methods. This review was performed according to systematic literature search of three major bibliographic databases (Scopus, PubMed, and Cochran).
Analysis of the literatue. Imaging studies play a very important role in kidney cancer. They allow one to assess the clinical stage, justify the extent of surgery and have an impact on the prognosis.
Conclusion. The field for research involves the use of magnetic resonance and positron emission tomography in diagnosing kidney changes.
Downloads
References
Kovacs G, Akhtar M, Beckwith BJ. Classification of renal cell tumors. J Pathol. 1997;83:131–133.
Chow WH, Dong LM, Devesa SS, contractor and former Senior Investigator. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010; 7(5): 245–257.
Kumar V, Abbas AK, Aster J. Patologia Robbins. Wrocław: Elsevier Urban & Partner; 2014.
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. Ca Cancer J Clin. 2017;67:7–30.
Motzer RJ, Jonasch E, Agarwal N, et al. Clinical Practice Guidelines in Oncology. Kidney Cancer, Version 2.2017.
Shuch B, Vourganti S, Ricketts CJ. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014;32:431–437.
Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203–205.
Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology. 2000;56:58–62.
Ficarra V, Prayer-Galetti T, Novella G, et al. Incidental detection beyond pathologicalfactors as prognostic predictor of renal cell carcinoma. EurUrol. 2003;43:663 – 669.
Patard JJ, Rodriguez A, Rioux-Leclercq N, Guille F, LobelB. Prognostic significance of the mode of detection in renaltumours. BJU Int. 2002;90:358 – 363.
Motzer RJ. Perspective: what next for treatment? Nature. 2016;537:111.
Malaeb BS, Martin DJ, Littooy FN, et al. The utility of screening renalultrasonography: identifying renal cell carcinoma in anelderly asymptomatic population. BJU Int. 2005;95:977 – 981.
National Cancer Intelligence Network. TNM Stage Group byCCG by Tumour Type for 10 Tumour Types. 2013.
Rossi SH, Hsu R, Blick C, et al. Meta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography; Systematic review. Br J Surg. 2017;104(6):648-659.
Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cellcarcinoma incidence and mortality. Eur Urol. 2015;67:519 – 530.
Mindrup SR, Pierre JS, Dahmoush L, Konety BR. Theprevalence of renal cell carcinoma diagnosed at autopsy. BJU Int. 2005;95: 31– 33.
Carver BS, Zibari GB, McBride V, Venable DD, EasthamJA. The incidence and implications of renal cell carcinomain cadaveric renal transplants at the time of organ recovery. Transplantation. 1999;67:1438 – 1440.
GOV.UK. Population Screening Programmes: National HealthService (NHS) Abdominal Aortic Aneurysm (AAA) Programme 2014–2015.
Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. English Bowel Cancer Screening Evaluation Committee. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut. 2012;61:1439 – 1446.
Breast Screening Programme, England – 2014–15.
Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due tomammography screening: results from the Norwegianscreening program. Ann Intern Med. 2012;156:491 – 499.
Bosniak MA. The current radiological approach to renal cysts. Radiology. 1986;158:1–10.
Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology. 2005;236:441–450.
Bosniak MA. Diffculties in classifying cystic lesions of the kidney. Urol Radiol. 1991;13: 91–93.
Bosniak MA. Diagnosis and management of patients with compli-cated cystic lesions of the kidney. AJR Am J Roentgenol. 1997;169:819–821.
Silverman SG, Israel GM, Herts BR, et al. Management of the in-cidental renal mass. Radiology. 2008;249:16–31
Sociedade Brasileira de Urologia. Câncer renal: diagnóstico e esta-diamento. Projeto Diretrizes. Associação Médica Brasileira e Con-selho. Federal de Medicina; 2006.
Rocha de Miranda CMN, de Miranda Maranhão CP, Justo dos Santos CJ, et al. Bosniak classification of renal cystic lesions according to multidetector computed tomography findings; Iconographic Essay.
Bertolotto M, Zappetti R, Cavallaro M, et al. Characterization of atypical cystic renal masses with MDCT: comparison of 5-mm axial images and thin multiplanar reconstructed images. AJR Am J Roentgenol. 2010;195:693–700.
Hartman DS, Weatherby E 3rd, Laskin WB, et al. Cystic renal cell carcinoma: CT findings simulating a benign hyperdense cyst. AJR Am J Roentgenol. 1992;159:1235–1237.
Israel GM, Bosniak MA. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR Am J Roentgenol. 2003;181:627–633
Bosniak MA. Problems in the radiologic diagnosis of renal parenchymal tumors. Urol Clin North Am. 1993;20:217–230
Whelan TF. Guidelines on the management of renal cyst disease. Can Urol Assoc J .2010;4:98–99.
Smith AD, Remer EM, Cox KL, et al. Bosniak category IIF and IIIcystic renal lesions: outcomes and associations. Radiology. 2012;262:152–160.
Israel GM, Hindman N, Bosniak MA. Evaluation of cystic renalmasses: comparison of CT and MR imaging by using the Bosniakclassification system. Radiology. 2004;231:365–371.
Hricak H, Demas BE, Williams RD, et al. Magnetic resonance imaging in the diagnosis and staging of renal and perirenal neoplasms. Radiology 1985;154:709–715.
Janus CL, Mendelson DS. Comparison of MRI and CT for study of renal and perirenal masses. Crit Rev Diagn Imaging. 1991;32:69–118
Park JW, Jo MK, Lee HM. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma. BJU Int. 2009;103:615–619.
Marc C.SmaldoneMD, Robert G.UzzoMD; Balancing Process and Risk: Standardizing Posttreatment Surveillance for Renal Cell Carcinoma; The Journal of Urology. 2013.190(2): 417-418.
Ferda J, Ferdova E, Hora M, et al. 18F-FDG-PET/CTin potentially advanced renal cell carcinoma: a rolein treatment decisions and prognosis estimation. Anticancer Res. 2013;33:2665.
Bouchelouche K, Choyke PL. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer. PET Clinics. 2015;10(3):361–374.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
